longevity – Learning with Lowell

In this episode, we dive deep into the world of longevity science and epigenetic testing with TruDiagnostic . We discuss the accuracy of biological age tests, the ethical and regulatory challenges in the industry, and...

What if understanding your health was as simple as ordering a blood test from home? This episode dives into how Instalab is reshaping preventative healthcare by providing accessible diagnostics and personalized care plans. Description:Join us...

In this episode of the Learning with Lowell podcast, host Lowell Thompson welcomes Olivia Lesslar and Alexander Layendecker, two experts in the fields of space life sciences and medicine. The discussion delves into the challenges...

“My long-term goal is to model the pathways involved in human aging in order to develop therapeutic interventions. I organize an annual aging conference in the Midwestern United States with the dual goal of promoting...

Dr. Peter Lidsky posits that aging is not merely a process of accumulating damages, as commonly believed, but rather a programmed adaptation akin to a part of the immune system. His hypothesis suggests that aging...

“Dr. Admasu earned his PhD in Biochemistry from national university of Singapore. In his PhD work he investigated interactions between lifespan extending drugs with the aim of engineering synergistic benefits in C. elegans. Dr. Admasu...

Joined with Jeffrey D. Gross, MD, a spine fellowship trained, board certified neurological surgeon. In his practice, he provides specialized treatment options for patients with neck and/or back problems, as well as brain and head...

video interview Dive into the fascinating world of cryptocurrencies, biotech innovation, and space exploration with Dane and Lowell. From navigating the complexities of crypto investments to discussing groundbreaking aging research funded by organizations like the...

Matthew and Lowell discussed the development of a new DNA targeting intervention to clear senescent cells. They highlighted the unique approach of Oisin, which targets cells based on their transcriptional activity rather than their appearance...

Dr. Kelsey Moody is a process-oriented biotechnology executive who has specialized in the study of aging and aging mechanisms for over a decade. Since 2013, He has successfully built Ichor from a living room start-up...